A Phase I Dose Escalation And Dose Expansion Study Of The Anti-Programmed Cell Death-1 (Pd-1) Antibody Ak105.Dusan Kotasek,Jermaine Coward,Paul L. de Souza,Craig Underhill,Xiaoping Jin,Baiyong Li,Yu Xia,Amy PrawiraJOURNAL OF CLINICAL ONCOLOGY(2019)引用 2|浏览22暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要